文献速递脊柱关节炎

银屑病关节炎滑液中CD4+而非CD8+ T细胞经TCR激活产生IL-17A,且与TNF调控不同炎症介质

Interleukin-17A Is Produced by CD4+ but Not CD8+ T Cells in Synovial Fluid Following T Cell Receptor Activation and Regulates Different Inflammatory Mediators Compared to Tumor Necrosis Factor in a Model of Psoriatic Arthritis Synovitis.
PubMed 文献 · Arthritis Rheumatol · 2020-07-08

该研究探讨银屑病关节炎(PsA)滑液中IL-17A与TNF的功能关系及CD8+ T细胞对IL-17A产生的贡献。流式显示PsA滑液CD4+和CD8+ T细胞均有IL-17A阳性,但仅CD4+ T细胞在抗CD3/抗CD28激活后分泌IL-17A;中和IL-17A与TNF对炎症因子和基质金属蛋白酶(MMP)的抑制谱有重叠但不同。

要点

  • PsA滑液中CD4+和CD8+ T细胞均表达IL-17A,但仅CD4+ T细胞经TCR激活后分泌IL-17A。
  • CD8+ T细胞仅在PMA/离子霉素刺激后分泌IL-17A,提示其非TCR依赖途径。
  • 中和IL-17A强抑制IL-6和IL-1β,抗TNF更有效降低MMP-3和MMP-13。

核心结论

  • PsA滑液CD8+ T细胞在TCR激活后不分泌IL-17A,与CD4+ T细胞不同。
  • 中和IL-17A与TNF在PsA滑膜炎体外模型中呈现重叠但不同的炎症介质调控效应。

研究设计与样本

  • 研究纳入20例活动性PsA滑液、22例未治疗PsA外周血和22例健康供者外周血,用流式细胞术鉴定IL-17A+ T细胞。
  • 从12例PsA滑液分选IL-17A+ T细胞,用抗CD3/抗CD28或PMA/离子霉素体外刺激,单独或与自体单核细胞或PsA成纤维样滑膜细胞(FLS)共培养。
  • 利用PsA滑液CD4+ T细胞与PsA FLS共培养体系评估中和IL-17A与TNF的差异效应。

主要发现

  • PsA滑液CD4+ T细胞IL-17A阳性中位数0.71%(四分位距0.35-1.50%),CD8+ T细胞中位数0.44%(四分位距0.17-1.86%)。
  • 仅CD4+ T细胞在抗CD3/抗CD28激活后分泌IL-17A,单独培养及与PsA单核细胞或PsA FLS共培养均如此(各P < 0.05)。
  • CD8+ T细胞仅在PMA/离子霉素刺激4或72小时后分泌IL-17A。
  • 中和IL-17A强抑制IL-6(P < 0.05)和IL-1β(P < 0.01),抗TNF更有效降低MMP-3(P < 0.05)和MMP-13。

临床怎么用

  • 在PsA滑膜炎中,CD4+ T细胞而非CD8+ T细胞是TCR依赖性IL-17A的主要来源。
  • IL-17A与TNF通路对炎症因子和MMP的调控各有侧重,支持联合或差异化靶向策略。

局限性

  • 体外刺激与共培养模型可能不能完全反映体内滑膜微环境。
  • 样本量有限,部分刺激条件例数较少(如单独刺激n=3)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Interleukin-17A (IL-17A) and tumor necrosis factor (TNF) contribute to the pathogenesis of psoriatic arthritis (PsA). However, their functional relationship in PsA synovitis has not been fully elucidated. Additionally, although CD8+ T cells in PsA have been recognized via flow cytometry as a source of IL-17A production, it is not clear whether CD8+ T cells secrete IL-17A under more physiologically relevant conditions in the context from PsA synovitis. This study was undertaken to clarify the roles of IL-17A and TNF in the synovial fluid (SF) from patients with PsA and investigate the impact of CD8+ T cells on IL-17A production. METHODS: IL-17A+ T cells were identified by flow cytometry in SF samples from 20 patients with active PsA, blood samples from 22 treatment-naive patients with PsA, and blood samples from 22 healthy donors. IL-17A+ T cells were sorted from 12 PsA SF samples and stimulated using anti-CD3/anti-CD28 or phorbol myristate acetate (PMA) and ionomycin ex vivo, alone (n = 3) or together with autologous monocytes (n = 3) or PsA fibroblast-like synoviocytes (FLS) (n = 5-6). To evaluate the differential allogeneic effects of neutralizing IL-17A and TNF, SF CD4+ T cells and PsA FLS cocultures were also used (n = 5-6). RESULTS: Flow cytometry analyses of SF samples from patients with PsA showed IL-17A positivity for CD4+ and CD8+ T cells (IL-17A, median 0.71% [interquartile range 0.35-1.50%] in CD4+ cells; median 0.44% [interquartile range 0.17-1.86%] in CD8+ T cells). However, only CD4+ T cells secreted IL-17A after anti-CD3/anti-CD28 activation, when cultured alone and in cocultures with PsA monocytes or PsA FLS (each P < 0.05). Remarkably, CD8+ T cells only secreted IL-17A after 4- or 72-hour stimulation with PMA/ionomycin. Anti-IL-17A and anti-TNF treatments both inhibited PsA synovitis ex vivo. Neutralizing IL-17A strongly inhibited IL-6 (P < 0.05) and IL-1β (P < 0.01), while anti-TNF treatment was more potent in reducing matrix metalloproteinase 3 (MMP-3) (P < 0.05) and MMP-13. CONCLUSION: CD8+ T cells, in contrast to CD4+ T cells, in SF specimens obtained from PsA patients did not secrete IL-17A following T cell receptor activation. Overlapping, but distinct, effects at the level of inflammatory cytokines and MMPs were found after neutralizing IL-17A or TNF ex vivo in a human model of PsA synovitis.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Xu X, Davelaar N, Mus AM, et al. Interleukin-17A Is Produced by CD4+ but Not CD8+ T Cells in Synovial Fluid Following T Cell Receptor Activation and Regulates Different Inflammatory Mediators Compared to Tumor Necrosis Factor in a Model of Psoriatic Arthritis Synovitis. Arthritis Rheumatol. 2020. PMID: 32243724. doi:10.1002/art.41271

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。